1. Home
  2. CDTX vs UTL Comparison

CDTX vs UTL Comparison

Compare CDTX & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • UTL
  • Stock Information
  • Founded
  • CDTX 2012
  • UTL 1984
  • Country
  • CDTX United States
  • UTL United States
  • Employees
  • CDTX N/A
  • UTL N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • UTL Power Generation
  • Sector
  • CDTX Health Care
  • UTL Utilities
  • Exchange
  • CDTX Nasdaq
  • UTL Nasdaq
  • Market Cap
  • CDTX 980.1M
  • UTL 842.0M
  • IPO Year
  • CDTX 2015
  • UTL N/A
  • Fundamental
  • Price
  • CDTX $63.31
  • UTL $51.52
  • Analyst Decision
  • CDTX Strong Buy
  • UTL Hold
  • Analyst Count
  • CDTX 11
  • UTL 1
  • Target Price
  • CDTX $52.11
  • UTL $55.00
  • AVG Volume (30 Days)
  • CDTX 659.9K
  • UTL 62.8K
  • Earning Date
  • CDTX 08-07-2025
  • UTL 08-04-2025
  • Dividend Yield
  • CDTX N/A
  • UTL 3.50%
  • EPS Growth
  • CDTX N/A
  • UTL N/A
  • EPS
  • CDTX N/A
  • UTL 2.93
  • Revenue
  • CDTX $302,000.00
  • UTL $486,900,000.00
  • Revenue This Year
  • CDTX N/A
  • UTL $13.90
  • Revenue Next Year
  • CDTX N/A
  • UTL $7.89
  • P/E Ratio
  • CDTX N/A
  • UTL $17.56
  • Revenue Growth
  • CDTX N/A
  • UTL N/A
  • 52 Week Low
  • CDTX $10.14
  • UTL $50.34
  • 52 Week High
  • CDTX $66.95
  • UTL $63.52
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 70.66
  • UTL 46.89
  • Support Level
  • CDTX $60.71
  • UTL $50.34
  • Resistance Level
  • CDTX $66.95
  • UTL $52.37
  • Average True Range (ATR)
  • CDTX 4.25
  • UTL 0.93
  • MACD
  • CDTX -0.39
  • UTL 0.07
  • Stochastic Oscillator
  • CDTX 79.25
  • UTL 38.94

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About UTL UNITIL Corporation

Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. The Company has two operating and reportable segments: Utility Electric Operations and Utility Gas Operations. Majority of revenue is gained from Electric Segment.

Share on Social Networks: